Document is current
Any future updates will be listed below
-
Authors
Elbert, Donald L. https://orcid.org/0000-0001-6480-9536
Patterson, Bruce W.
Lucey, Brendan P. https://orcid.org/0000-0001-5400-825X
Benzinger, Tammie L. S. https://orcid.org/0000-0002-8114-0552
Bateman, Randall J. https://orcid.org/0000-0002-7729-1702
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK 056341)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (K76 AG054863, R01AG054567, P01AG003991)
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS065667)
- License Information
-
More Information
Article History
Received: 12 March 2021
Accepted: 27 December 2021
First Online: 27 January 2022
Competing interests
: The authors declare the following competing interests: D.L.E consults for DIAN-TU, which did not support this work. Washington University and R.J.B. have an equity ownership interest in C2N Diagnostics and received royalty income based on SILK technology licensed by Washington University to C2N Diagnostics. R.J.B. receives income from C2N Diagnostics for serving on the scientific advisory board. Washington University, with R.J.B. as co-inventor, has submitted the US nonprovisional patent application “Methods for Measuring the Metabolism of CNS Derived Biomolecules In Vivo” and provisional patent application “Plasma Based Methods for Detecting C.N.S. Amyloid Deposition.” C2N Diagnostics did not support this work. T.B. has served on advisory boards for Eli Lilly, Eisai and Biogen, is on the Biogen Speakers Bureau, and has received research funding from Avid Radiopharmaceuticals (a wholly owned subsidiary of Eli Lilly). B.P.L. consults for Merck. These relationships are not related to the content in the manuscript. The remaining author declares no competing interests.
